ArticleHaemophilia : the official journal of the World Federation of Hemophilia
Reference Values for the Haemophilia Joint Health Score in Patients With Severe Haemophilia Derived From the Canadian Bleeding Disorder Registry.
Article in Haemophilia : the official journal of the World Federation of Hemophilia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeople with haemophilia (PwH) are at increased risk of joint bleeding, often leading to haemophilic arthropathy. The Haemophilia Joint Health Score (HJHS) is widely used to evaluate joint health, but its interpretability is limited by the lack of age-based reference values.
objectiveThis study aimed to develop national reference values for the HJHS in individuals with severe haemophilia using data from the Canadian Bleeding Disorder Registry (CBDR).
methodsThis cross-sectional study used CBDR data from 1 January 2018 to 31 December 2024. Participants aged ≥4 years with severe Haemophilia A or B and at least one HJHS score were included. Generalised Additive Models for Location, Scale, and Shape (GAMLSS) were used to estimate reference percentiles. Model performance was assessed using 100-fold cross-validation.
resultsA total of 551 participants with severe haemophilia were included, comprising 255 paediatric (<18 years of age) and 296 adult patients (mean age: 24 ± 17 years; range: 4-75; 87% with Haemophilia A). Reference percentiles (fifth to 95th) were generated for ages 4-70 years, demonstrating a positive association between age and HJHS scores. Cross-validation showed acceptable model consistency.
conclusionThis study provides the first national age-based reference values for the HJHS in individuals with severe Haemophilia A and B. These values allow clinicians to interpret joint health scores relative to age-specific expectations. Future research should extend age-specific HJHS reference values to additional national registries to strengthen global interpretation and comparison of joint health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.